A nose drop that could help prevent meningitis is being tested by UK doctors in a world-first trial.
The nose drops remain in the nose and prompts an immune response. Around 10 per cent of ‘healthy carriers’ carry the bacteria responsible for meningitis in the back of their noses and throats without anysigns or symptoms.
The treatment was developed at the NIHR Southampton Biomedical Research Centre. Professor Robert Read, director at the Centre,said: “The bacteria settled and it caused an immune response which prevented the acquisition of harmful bacteria in a number of patients”.
Read the full story here